GH Research
GHRS | NASDAQ
$27.96
+$0.03 (+0.11%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 335K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -335K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -60.68M | -50.31M | -41.22M | -30.55M | -15.1M | -446K |
Interest Income | 2.63M | 2.63M | 1.89M | 858K | 9 | n/a |
Pretax Income | -48.26M | -38.96M | -35.59M | -22.46M | -9.2M | -446K |
Net Income | -48.26M | -38.96M | -35.59M | -22.46M | -9.2M | -446K |
Selling & General & Admin | 21.61M | 15M | 11.12M | 10.06M | 6.54M | 108K |
Research & Development | 38.73M | 35.02M | 29.82M | 20.48M | 8.55M | 338K |
Other Expenses | n/a | 294K | 280K | 14K | 5K | n/a |
Operating Expenses | 60.34M | 50.31M | 41.22M | 30.55M | 15.1M | 446K |
Interest Expense | 463K | 717K | 723K | n/a | 9K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.68M | 50.31M | 41.22M | 30.55M | 15.1M | 446K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.04M | 52.03M | 52.02M | 52.02M | 52.02M | 30.37M |
Shares Outstanding (Diluted) | 61.04M | 52.03M | 52.02M | 52.02M | 52.02M | 30.37M |
EPS (Basic) | -0.79 | -0.75 | -0.68 | -0.14 | -0.18 | -0.01 |
EPS (Diluted) | -0.79 | -0.75 | -0.68 | -0.14 | -0.18 | -0.01 |
EBITDA | -47.46M | -38.6M | -35.21M | -22.41M | -9.17M | n/a |
EBIT | -47.8M | -38.91M | -35.52M | -22.46M | -9.19M | -446K |
Depreciation & Amortization | 335K | 315K | 315K | 47K | 19K | 446K |
Add to Watchlist
Select watchlists to add or remove GHRS